{"id":"W4379281663","doi":"10.1200/jco.2023.41.16_suppl.4538","title":"Characterizing progression to subsequent lines of therapy in metastatic renal cell carcinoma (mRCC) after nivolumab plus ipilimumab (Nivo+Ipi): Results from the International mRCC Database Consortium (IMDC).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; University of British Columbia; Dalhousie University; University of Toronto; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; BC Cancer Agency; University of Calgary","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Internal medicine; Renal cell carcinoma; Oncology; Systemic therapy; Performance status; Progressive disease; Cancer; Expanded access; Disease; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002887407,0.0001912075,0.0006106325,0.001690097,0.0002719282,0.0008094816,0.0006529381,0.0003986706,0.001070002],"category_scores_gemma":[0.005475358,0.0001317917,0.0006785884,0.002374306,0.0001478232,0.0005163013,0.0007552174,0.0003662354,0.0003303168],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008494678,"about_ca_system_score_gemma":0.0007876262,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00914436,"about_ca_topic_score_gemma":0.01394177,"domain_scores_codex":[0.9982389,0.0004868886,0.0003882441,0.0003594765,0.0003830843,0.0001433181],"domain_scores_gemma":[0.9924005,0.001656883,0.003852215,0.0006440331,0.0008273825,0.0006189189],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005752374,0.00003739563,0.995237,0.00005753719,0.0001130124,0.00002395581,0.0000327737,0.00009880042,0.0000778605,0.000008629587,0.0003681191,0.003369684],"study_design_scores_gemma":[0.00004826151,0.0002132845,0.9980633,0.000029192,0.0001096571,0.0001760442,0.00007347411,0.000505176,0.0001424357,0.00001031916,0.0006241039,0.00000472629],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9845865,0.001167525,0.0001394667,0.0000614657,0.000005001577,0.00005119456,0.01353435,0.0000134533,0.0004409501],"genre_scores_gemma":[0.9801652,0.0003639206,0.0003025096,0.00006277305,0.00001125216,0.00005798685,0.01886349,0.000005429589,0.0001673784],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00914436,"threshold_uncertainty_score":0.01818228,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1641714023669791,"score_gpt":0.4356573498684445,"score_spread":0.2714859475014655,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}